Dual roles of extracellular signal-regulated kinase (ERK) in quinoline compound BPIQ-induced apoptosis and anti-migration of human non-small cell lung cancer cells

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1475-2867

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Dual roles of extracellular signal-regulated kinase (ERK) in quinoline compound BPIQ-induced apoptosis and anti-migration of human non-small cell lung cancer cells ; volume:17 ; number:1 ; day:7 ; month:3 ; year:2017 ; pages:1-13 ; date:12.2017
Cancer cell international ; 17, Heft 1 (7.3.2017), 1-13, 12.2017

Keyword: Krebs
Onkologie

Creator: Fong, Yao

Contributor: Wu, Chang-Yi
Chang, Kuo-Feng
Chen, Bing-Hung
Chou, Wan-Ju
Tseng, Chih-Hua
Chen, Yen-Chun
Wang, Hui-Min David
Chen, Yeh-Long
Chiu, Chien-Chih
SpringerLink (Online service)

DOI: 10.1186/s12935-017-0403-0

URN: urn:nbn:de:1111-201703293087

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:48 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Fong, Yao
Wu, Chang-Yi
Chang, Kuo-Feng
Chen, Bing-Hung
Chou, Wan-Ju
Tseng, Chih-Hua
Chen, Yen-Chun
Wang, Hui-Min David
Chen, Yeh-Long
Chiu, Chien-Chih
SpringerLink (Online service)

Other Objects (12)

Identification of a novel quinoline-based DNA demethylating compound highly potent in cancer cells

Correction: Identification of a novel quinoline-based DNA demethylating compound highly potent in cancer cells

Paclitaxel combined with Compound K inducing pyroptosis of non-small cell lung cancer cells by regulating Treg/Th17 balance

ERK inhibitor ASN007 effectively overcomes acquired resistance to EGFR inhibitor in non‐small cell lung cancer

MicroRNA-330-3p promotes cell invasion and metastasis in non-small cell lung cancer through GRIA3 by activating MAPK/ERK signaling pathway

Inhibition of FASN suppresses the malignant biological behavior of non-small cell lung cancer cells via deregulating glucose metabolism and AKT/ERK pathway

Epiregulin increases stemness-associated genes expression and promotes chemoresistance of non-small cell lung cancer via ERK signaling

USP32 facilitates non-small cell lung cancer progression via deubiquitinating BAG3 and activating RAF-MEK-ERK signaling pathway

Non-small cell lung cancer treatment

Targeting ERK-MYD88 interaction leads to ERK dysregulation and immunogenic cancer cell death

Identification of a novel quinoline-based DNA demethylating compound highly potent in cancer cells

Correction: Identification of a novel quinoline-based DNA demethylating compound highly potent in cancer cells

Paclitaxel combined with Compound K inducing pyroptosis of non-small cell lung cancer cells by regulating Treg/Th17 balance

ERK inhibitor ASN007 effectively overcomes acquired resistance to EGFR inhibitor in non‐small cell lung cancer

MicroRNA-330-3p promotes cell invasion and metastasis in non-small cell lung cancer through GRIA3 by activating MAPK/ERK signaling pathway

Inhibition of FASN suppresses the malignant biological behavior of non-small cell lung cancer cells via deregulating glucose metabolism and AKT/ERK pathway

Epiregulin increases stemness-associated genes expression and promotes chemoresistance of non-small cell lung cancer via ERK signaling

USP32 facilitates non-small cell lung cancer progression via deubiquitinating BAG3 and activating RAF-MEK-ERK signaling pathway

Non-small cell lung cancer treatment

Targeting ERK-MYD88 interaction leads to ERK dysregulation and immunogenic cancer cell death

Identification of a novel quinoline-based DNA demethylating compound highly potent in cancer cells

Correction: Identification of a novel quinoline-based DNA demethylating compound highly potent in cancer cells

Paclitaxel combined with Compound K inducing pyroptosis of non-small cell lung cancer cells by regulating Treg/Th17 balance

ERK inhibitor ASN007 effectively overcomes acquired resistance to EGFR inhibitor in non‐small cell lung cancer

MicroRNA-330-3p promotes cell invasion and metastasis in non-small cell lung cancer through GRIA3 by activating MAPK/ERK signaling pathway

Inhibition of FASN suppresses the malignant biological behavior of non-small cell lung cancer cells via deregulating glucose metabolism and AKT/ERK pathway

Epiregulin increases stemness-associated genes expression and promotes chemoresistance of non-small cell lung cancer via ERK signaling

USP32 facilitates non-small cell lung cancer progression via deubiquitinating BAG3 and activating RAF-MEK-ERK signaling pathway

Non-small cell lung cancer treatment

Targeting ERK-MYD88 interaction leads to ERK dysregulation and immunogenic cancer cell death

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Dual roles of extracellular signal-regulated kinase (ERK) in quinoline compound BPIQ-induced apoptosis and anti-migration of human non-small cell lung cancer cells

Object Details

References and Relationships

Classification and Topics

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Identification of a novel quinoline-based DNA demethylating compound highly potent in cancer cells

Correction: Identification of a novel quinoline-based DNA demethylating compound highly potent in cancer cells

Paclitaxel combined with Compound K inducing pyroptosis of non-small cell lung cancer cells by regulating Treg/Th17 balance

ERK inhibitor ASN007 effectively overcomes acquired resistance to EGFR inhibitor in non‐small cell lung cancer

MicroRNA-330-3p promotes cell invasion and metastasis in non-small cell lung cancer through GRIA3 by activating MAPK/ERK signaling pathway

Inhibition of FASN suppresses the malignant biological behavior of non-small cell lung cancer cells via deregulating glucose metabolism and AKT/ERK pathway

Epiregulin increases stemness-associated genes expression and promotes chemoresistance of non-small cell lung cancer via ERK signaling

USP32 facilitates non-small cell lung cancer progression via deubiquitinating BAG3 and activating RAF-MEK-ERK signaling pathway

Non-small cell lung cancer treatment

Non-small cell lung cancer treatment

Non-small cell lung cancer treatment

Targeting ERK-MYD88 interaction leads to ERK dysregulation and immunogenic cancer cell death

Identification of a novel quinoline-based DNA demethylating compound highly potent in cancer cells

Correction: Identification of a novel quinoline-based DNA demethylating compound highly potent in cancer cells

Paclitaxel combined with Compound K inducing pyroptosis of non-small cell lung cancer cells by regulating Treg/Th17 balance

ERK inhibitor ASN007 effectively overcomes acquired resistance to EGFR inhibitor in non‐small cell lung cancer

MicroRNA-330-3p promotes cell invasion and metastasis in non-small cell lung cancer through GRIA3 by activating MAPK/ERK signaling pathway

Inhibition of FASN suppresses the malignant biological behavior of non-small cell lung cancer cells via deregulating glucose metabolism and AKT/ERK pathway

Epiregulin increases stemness-associated genes expression and promotes chemoresistance of non-small cell lung cancer via ERK signaling

USP32 facilitates non-small cell lung cancer progression via deubiquitinating BAG3 and activating RAF-MEK-ERK signaling pathway

Non-small cell lung cancer treatment

Non-small cell lung cancer treatment

Non-small cell lung cancer treatment

Targeting ERK-MYD88 interaction leads to ERK dysregulation and immunogenic cancer cell death

Identification of a novel quinoline-based DNA demethylating compound highly potent in cancer cells

Correction: Identification of a novel quinoline-based DNA demethylating compound highly potent in cancer cells

Paclitaxel combined with Compound K inducing pyroptosis of non-small cell lung cancer cells by regulating Treg/Th17 balance

ERK inhibitor ASN007 effectively overcomes acquired resistance to EGFR inhibitor in non‐small cell lung cancer

MicroRNA-330-3p promotes cell invasion and metastasis in non-small cell lung cancer through GRIA3 by activating MAPK/ERK signaling pathway

Inhibition of FASN suppresses the malignant biological behavior of non-small cell lung cancer cells via deregulating glucose metabolism and AKT/ERK pathway

Epiregulin increases stemness-associated genes expression and promotes chemoresistance of non-small cell lung cancer via ERK signaling

USP32 facilitates non-small cell lung cancer progression via deubiquitinating BAG3 and activating RAF-MEK-ERK signaling pathway

Non-small cell lung cancer treatment

Non-small cell lung cancer treatment

Non-small cell lung cancer treatment

Targeting ERK-MYD88 interaction leads to ERK dysregulation and immunogenic cancer cell death

Related objects

Reset password